(photo credit: INGIMAGE / ASAP)
Some of the medical technologies in the health basket will benefit over 21,000 people (screening tests for Smith-Lemli- Opitz, a genetic disease in Ashkenazi Jews), while three will help 11 patients, including a twomonth- old baby suffering from short-bowel syndrome and rare metabolic diseases. Two other screening tests will look for an estimated 500 carriers of a genetic disease found in Jews of Bukharan origin, and another will check for genetic disorders found in about 930 Arabs and Druse.
Fully half of the basket will go to treat cancers. NIS 40 million will be allocated to expand free basic dental care at health fund clinics to age 15. Patients with non-squamous lung cancer will be able to get a new immunotherapy drug. Duodopa, a drug for Parkinson’s disease, was added for epilepsy patients who have not benefited from other drugs.
Hearing aids for adults aged 31 to 50 who were not previously eligible will now be provided.
People who contracted benign tumors in their jaws and need rehabilitation will get it at state cost, as will women who froze ovarian tissue for becoming pregnant after chemotherapy for cancer that would have destroyed the tissue.
Drugs for cardiovascular diseases include Multaq, Coralan and Entrestro. For dermatology they are Picato gel, Otexia and Humira. For type-2 diabetes they include Forxiga and Jardiance (but only for 34,570 patients who have certain indications). For hemato-oncology they are Venclexta, Bosulif, Opdiva, Difolta, Empliciti, Darzalex and Ninlaro.
For lung hypertension they include Viagra and Cialis, and for liver diseases, a number of new drugs will replace less effective ones at no extra cost.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>